{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:29:12Z","timestamp":1790314152700,"version":"4.1.0"},"reference-count":214,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.biopha.2023.115603","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T12:24:05Z","timestamp":1695903845000},"page":"115603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The role and application of three IFN-related reactions in psoriasis"],"prefix":"10.1016","volume":"167","author":[{"given":"Jiaming","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115603_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2022-329134","article-title":"Multivalent tyrosine kinase inhibition promotes T cell recruitment to immune-desert gastric cancers by restricting epithelial-mesenchymal transition via tumour-intrinsic IFN-\u03b3 signalling","author":"Cao","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2023.115603_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03512-22","article-title":"SHIP1 modulates antimalarial immunity by bridging the crosstalk between type I IFN signaling and autophagy","author":"Li","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.biopha.2023.115603_bib3","article-title":"The gamble between oncolytic virus therapy and IFN","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib4","article-title":"Vaccine-induced protection against SARS-CoV-2 requires IFN-\u03b3-driven cellular immune response","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2023.115603_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2133.1991.tb14774.x","article-title":"Psoriasis induced by interferon-alpha","volume":"125","author":"Funk","year":"1991","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115603_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2340\/0001555573395","article-title":"Psoriasis exacerbation induced by interferon-alpha. Report of two cases","volume":"73","author":"Pauluzzi","year":"1993","journal-title":"Acta Derm. -Venereol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115603_bib7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2230.2000.00655-4.x","article-title":"Exacerbation of psoriasis by interferon-alpha therapy for hepatitis C","volume":"25","author":"Downs","year":"2000","journal-title":"Clin. Exp. Dermatol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib8","first-page":"107","article-title":"Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B","volume":"15","author":"Ketikoglou","year":"2005","journal-title":"Eur. J. Dermatol.: EJD"},{"issue":"5","key":"10.1016\/j.biopha.2023.115603_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052505","article-title":"Type I interferons in systemic lupus erythematosus: a journey from bench to bedside","volume":"23","author":"Sim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.115603_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030864","article-title":"Optimal selection of IFN-\u03b1-inducible genes to determine type i interferon signature improves the diagnosis of systemic lupus erythematosus","volume":"11","author":"Demers-Mathieu","year":"2023","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.biopha.2023.115603_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8081244","article-title":"Molecular profiling of cutaneous lupus lesions identifies subgroups distinct from clinical phenotypes","volume":"8","author":"Berthier","year":"2019","journal-title":"J. Clin. Med."},{"issue":"9","key":"10.1016\/j.biopha.2023.115603_bib12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s40265-014-0240-6","article-title":"Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment","volume":"74","author":"Hornung","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2023.115603_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1151695","article-title":"Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients","volume":"14","author":"Qian","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115603_bib14","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jid.2022.10.025","article-title":"Skin IL-17A and IFN-\u03b3 production correlate with disease severity in patients with psoriasis and streptococcal infection","volume":"143","author":"Della","year":"2023","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115603_bib15","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/art.41627","article-title":"Predictive significance of serum interferon-inducible protein score for response to treatment in systemic sclerosis-related interstitial lung disease","volume":"73","author":"Assassi","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115603_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis Pathogenesis and Treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2023.115603_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2017.07.007","article-title":"Psoriasis: a mixed autoimmune and autoinflammatory disease","volume":"49","author":"Liang","year":"2017","journal-title":"Curr. Opin. Immunol."},{"issue":"9997","key":"10.1016\/j.biopha.2023.115603_bib19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.115603_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.916701","article-title":"Metabolic syndrome in psoriasis is associated with upregulation of CXCL16 on monocytes and a dysbalance in innate lymphoid cells","volume":"13","author":"Schielke","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115603_bib21","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10787-023-01178-0","article-title":"Review of natural compounds for potential psoriasis treatment","volume":"31","author":"Elkhawaga","year":"2023","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/15476286.2023.2223486","article-title":"Implications of LncRNAs and CircRNAs in psoriasis: a review","volume":"20","author":"Shi","year":"2023","journal-title":"RNA Biol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib23","first-page":"210","volume":"33","author":"Scarpa","year":"2006","journal-title":"Psoriasis, psoriatic Arthritis, Or. psoriatic Dis. ? J. Rheumatol."},{"issue":"12","key":"10.1016\/j.biopha.2023.115603_bib24","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ncprheum0670","article-title":"Psoriatic disease--from skin to bone","volume":"3","author":"Ritchlin","year":"2007","journal-title":"Nat. Clin. Pract. Rheumatol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115603_bib25","article-title":"Cardiometabolic disorders in psoriatic disease","volume":"19","author":"Sobchak","year":"2017","journal-title":"Curr. Rheuma Rep."},{"key":"10.1016\/j.biopha.2023.115603_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02342","article-title":"Targeting the janus kinase family in autoimmune skin diseases","volume":"10","author":"Howell","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115603_bib27","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s10067-016-3295-9","article-title":"Psoriatic arthritis and psoriasis: differential diagnosis","volume":"35","author":"Napolitano","year":"2016","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol.: JEADV"},{"issue":"18","key":"10.1016\/j.biopha.2023.115603_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184347","article-title":"Risk factors for the development of psoriasis","volume":"20","author":"Kamiya","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115603_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1191645","article-title":"Pathogenic role of S100 proteins in psoriasis","volume":"14","author":"Liang","year":"2023","journal-title":"Front. Immunol."},{"issue":"927","key":"10.1016\/j.biopha.2023.115603_bib31","first-page":"258","article-title":"Virus interference. I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc. R. Soc. Lond. Ser. B, Biol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2023.115603_bib32","first-page":"1627","article-title":"[Inhibition of vaccinia infection by a liquid factor in tissues infected by homologous virus]","volume":"152","author":"Nagano","year":"1958","journal-title":"Comptes rendus Des. Seances De. la Soc. De. Biol. Et. De. Ses. Fil."},{"issue":"9","key":"10.1016\/j.biopha.2023.115603_bib33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nri1684","article-title":"The yin and yang of type I interferon activity in bacterial infection","volume":"5","author":"Decker","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2023.115603_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","article-title":"Interferons, interferon-like cytokines, and their receptors","volume":"202","author":"Pestka","year":"2004","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cytogfr.2014.10.011","article-title":"Type I IFN family members: similarity, differences and interaction","volume":"26","author":"Capobianchi","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"11","key":"10.1016\/j.biopha.2023.115603_bib36","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/annrheumdis-2018-213197","article-title":"Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa","volume":"77","author":"Sarkar","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jid.2021.05.029","article-title":"IFN-\u03ba is a rheostat for development of psoriasiform inflammation","volume":"142","author":"Gharaee-Kermani","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2023.115603_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.788940","article-title":"The role of helper T cells in psoriasis","volume":"12","author":"Hu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.115603_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2018.06.012","article-title":"Plasmacytoid dendritic cell in immunity and cancer","volume":"322","author":"Mitchell","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115603_bib40","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1111\/all.14763","article-title":"Regulatory B cells, A to Z","volume":"76","author":"Jansen","year":"2021","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"issue":"9","key":"10.1016\/j.biopha.2023.115603_bib42","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nri1900","article-title":"IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors","volume":"6","author":"Honda","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2023.115603_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front. Immunol."},{"issue":"5\u20136","key":"10.1016\/j.biopha.2023.115603_bib44","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/15216540600702206","article-title":"Toll-like receptor signaling and IRF transcription factors","volume":"58","author":"Honda","year":"2006","journal-title":"IUBMB life"},{"issue":"4","key":"10.1016\/j.biopha.2023.115603_bib45","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrrheum.2018.31","article-title":"Type I interferon in rheumatic diseases","volume":"14","author":"Muskardin","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.biopha.2023.115603_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00342","article-title":"Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5","volume":"5","author":"Reikine","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.115603_bib47","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115603_bib48","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2023.115603_bib51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2020.07.002","article-title":"The pros and cons of interferons for oncolytic virotherapy","volume":"56","author":"Geoffroy","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"10","key":"10.1016\/j.biopha.2023.115603_bib52","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1089\/jir.2019.0044","article-title":"The IFN-\u03bb4 Conundrum: When a Good Interferon Goes Bad","volume":"39","author":"Onabajo","year":"2019","journal-title":"J. Interferon Cytokine Res.: Off. J. Int. Soc. Interferon Cytokine Res."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib53","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat. Genet."},{"issue":"15","key":"10.1016\/j.biopha.2023.115603_bib54","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1128\/JVI.79.15.9608-9617.2005","article-title":"Gene expression and antiviral activity of alpha\/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells","volume":"79","author":"Osterlund","year":"2005","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.biopha.2023.115603_bib55","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1084\/jem.20092720","article-title":"Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC.","volume":"207","author":"Lauterbach","year":"2010","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.biopha.2023.115603_bib56","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/icb.2011.109","article-title":"Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent","volume":"90","author":"Hillyer","year":"2012","journal-title":"Immunol. Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115603_bib57","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.4049\/jimmunol.182.3.1296","article-title":"Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection","volume":"182","author":"Wang","year":"2009","journal-title":"J. Immunol. (Baltim., Md: 1950)"},{"issue":"6","key":"10.1016\/j.biopha.2023.115603_bib58","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1128\/JVI.01956-12","article-title":"Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells","volume":"87","author":"Ioannidis","year":"2013","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115603_bib59","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s12250-020-00330-2","article-title":"Herpesviruses and the Type III Interferon System","volume":"36","author":"Yin","year":"2021","journal-title":"Virol. Sin."},{"issue":"8","key":"10.1016\/j.biopha.2023.115603_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003514","article-title":"A systematic analysis of host factors reveals a Med23-interferon-\u03bb regulatory axis against herpes simplex virus type 1 replication","volume":"9","author":"Griffiths","year":"2013","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.biopha.2023.115603_bib61","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/JPER.17-0349","article-title":"mRNA expression of IFN-\u03bbs in the gingival tissue of patients with chronic or aggressive periodontitis: A polymerase chain reaction study","volume":"89","author":"Bilichodmath","year":"2018","journal-title":"J. Periodontol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115603_bib62","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrc.2016.14","article-title":"Antitumour actions of interferons: implications for cancer therapy","volume":"16","author":"Parker","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2023.115603_bib63","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/icb.2012.9","article-title":"The interferons and their receptors--distribution and regulation.","volume":"90","author":"de Weerd","year":"2012","journal-title":"Immunol. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115603_bib64","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cytogfr.2014.07.015","article-title":"Interferons: Success in anti-viral immunotherapy","volume":"25","author":"Lin","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib65","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1159\/000485116","article-title":"1 Dynamically regulates antiviral innate immune responses during viral infection","volume":"44","author":"Zan","year":"2017","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol., Biochem., Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115603_bib66","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1159\/000495897","article-title":"Type I interferons: distinct biological activities and current applications for viral infection","volume":"51","author":"Li","year":"2018","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol., Biochem., Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115603_bib67","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/jir.1997.17.121","article-title":"GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression","volume":"17","author":"Decker","year":"1997","journal-title":"J. Interferon Cytokine Res.: Off. J. Int. Soc. Interferon Cytokine Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib68","doi-asserted-by":"crossref","first-page":"27","DOI":"10.18388\/abp.2007_3266","article-title":"STAT activation and differential complex formation dictate selectivity of interferon responses","volume":"54","author":"Wesoly","year":"2007","journal-title":"Acta Biochim. Pol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib69","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J. Leukoc. Biol."},{"issue":"5168","key":"10.1016\/j.biopha.2023.115603_bib70","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1126\/science.8016643","article-title":"Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA","volume":"265","author":"Steimle","year":"1994","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.biopha.2023.115603_bib71","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/JVI.80.9.4501-4509.2006","article-title":"Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo","volume":"80","author":"Ank","year":"2006","journal-title":"J. Virol."},{"issue":"Pt 2","key":"10.1016\/j.biopha.2023.115603_bib72","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1042\/bj20021935","article-title":"Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3","volume":"370","author":"Dumoutier","year":"2003","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.biopha.2023.115603_bib73","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2006.09.052","article-title":"Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics","volume":"131","author":"Marcello","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2023.115603_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2018.11.022","article-title":"The influence of interferon on healthy and diseased skin","volume":"132","author":"Hile","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2023.115603_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2014.11.013","article-title":"Human keratinocytes restrict chikungunya virus replication at a post-fusion step","volume":"476","author":"Bernard","year":"2015","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib76","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1128\/JVI.02137-15","article-title":"Interferon kappa inhibits human papillomavirus 31 transcription by inducing Sp100 proteins","volume":"90","author":"Habiger","year":"2016","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115603_bib77","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/art.39987","article-title":"Ultraviolet B irradiation causes stimulator of interferon genes-dependent production of protective type i interferon in mouse skin by recruited inflammatory monocytes","volume":"69","author":"Sontheimer","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"20","key":"10.1016\/j.biopha.2023.115603_bib78","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142067","article-title":"Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin","volume":"5","author":"Jiang","year":"2020","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.biopha.2023.115603_bib79","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1089\/jir.1997.17.721","article-title":"The expression and modulation of IFN-alpha and IFN-beta in human keratinocytes","volume":"17","author":"Fujisawa","year":"1997","journal-title":"J. Interferon Cytokine Res.: Off. J. Int. Soc. Interferon Cytokine Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib80","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jid.2016.09.008","article-title":"Lupus skin is primed for IL-6 inflammatory responses through a keratinocyte-mediated autocrine type i interferon loop","volume":"137","author":"Stannard","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115603_bib81","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00403-002-0348-5","article-title":"Upregulation of interleukin-18 expression in mouse primary keratinocytes induced to differentiate by calcium","volume":"294","author":"Kong","year":"2002","journal-title":"Arch. Dermatol. Res."},{"issue":"10","key":"10.1016\/j.biopha.2023.115603_bib82","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.jid.2017.03.041","article-title":"STING is involved in antiviral immune response against VZV infection via the induction of type I and III IFN pathways","volume":"137","author":"Kim","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115603_bib83","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jid.2017.03.016","article-title":"IL-21 May promote granzyme B-dependent NK\/plasmacytoid dendritic cell functional interaction in cutaneous lupus erythematosus","volume":"137","author":"Salvi","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2023.115603_bib84","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaut.2015.07.002","article-title":"Type I and II interferon signatures in Sjogren's syndrome pathogenesis: contributions in distinct clinical phenotypes and sjogren's related lymphomagenesis","volume":"63","author":"Nezos","year":"2015","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.biopha.2023.115603_bib85","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jdcr.2017.04.011","article-title":"Cutaneous purpura of Sj\u00f6gren syndrome successfully treated with hydroxychloroquine","volume":"3","author":"Hile","year":"2017","journal-title":"JAAD case Rep."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib86","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/0961203313515764","article-title":"Annular erythema in primary Sjogren's syndrome: description of 43 non-Asian cases","volume":"23","author":"Brito-Zer\u00f3n","year":"2014","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.biopha.2023.115603_bib87","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/jid.2012.149","article-title":"Type I IFNs at the interface between cutaneous immunity and epidermal remodeling","volume":"132","author":"Conrad","year":"2012","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib88","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.0022-202X.2003.22113.x","article-title":"In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered","volume":"122","author":"van der Fits","year":"2004","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115603_bib89","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/jir.1994.14.229","article-title":"The type I interferon system is locally activated in psoriatic lesions","volume":"14","author":"Schmid","year":"1994","journal-title":"J. Interferon Res."},{"issue":"3","key":"10.1016\/j.biopha.2023.115603_bib90","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.0022-202X.2004.22322.x","article-title":"Interferon alpha-inducible protein 27 (IFI27) is upregulated in psoriatic skin and certain epithelial cancers","volume":"122","author":"Suomela","year":"2004","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib91","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/43.1.7822763","article-title":"Expression of MxA protein in inflammatory dermatoses","volume":"43","author":"F\u00e4h","year":"1995","journal-title":"J. Histochem. Cytochem.: Off. J. Histochem. Soc."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib92","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1468-3083.2003.00583.x","article-title":"Lichen planus and leukocytoclastic vasculitis induced by interferon alpha-2b in a subject with HCV-related chronic active hepatitis","volume":"17","author":"Pinto","year":"2003","journal-title":"J. Eur. Acad. Dermatol. Venereol.: JEADV"},{"issue":"3","key":"10.1016\/j.biopha.2023.115603_bib93","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jdcr.2017.09.034","article-title":"Erosive oral lichen planus after pegylated-interferon therapy for chronic hepatitis B","volume":"4","author":"Choi","year":"2018","journal-title":"JAAD case Rep."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib94","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2007.083246","article-title":"Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced?","volume":"68","author":"H\u00fcgle","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib95","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jdcr.2014.10.002","article-title":"Interferon beta-1a-induced morphea","volume":"1","author":"Bezalel","year":"2015","journal-title":"JAAD case Rep."},{"key":"10.1016\/j.biopha.2023.115603_bib96","first-page":"1","article-title":"MicroRNA-125b mediates Interferon-\u03b3-induced downregulation of the vitamin D receptor in systemic lupus erythematosus","author":"Gu","year":"2023","journal-title":"Z. fur Rheumatol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib97","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.autrev.2014.10.014","article-title":"The autoimmune basis of alopecia areata: a comprehensive review","volume":"14","author":"Islam","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2023.115603_bib98","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/exd.12489","article-title":"The role of cytokines and chemokines in the T-cell-mediated autoimmune process in alopecia areata","volume":"23","author":"Ito","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.biopha.2023.115603_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108513","article-title":"Psoriatic arthritis under the influence of IFN\u03b3","volume":"218","author":"Dai","year":"2020","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115603_bib100","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/jid.2012.17","article-title":"Increased expression of Cxcr3 and its ligands, Cxcl9 and Cxcl10, during the development of alopecia areata in the mouse","volume":"132","author":"McPhee","year":"2012","journal-title":"J. Invest. Dermatol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115603_bib101","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/jid.2009.65","article-title":"Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis","volume":"129","author":"Harper","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115603_bib102","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2174\/138920212801619241","article-title":"SKINOMICS: Transcriptional Profiling in Dermatology and Skin Biology","volume":"13","author":"Blumenberg","year":"2012","journal-title":"Curr. Genom."},{"issue":"3","key":"10.1016\/j.biopha.2023.115603_bib103","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115603_bib104","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.biopha.2023.115603_bib105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115603_bib106","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.jaci.2020.12.657","article-title":"Cross-talk between IFN-\u03b3 and TWEAK through miR-149 amplifies skin inflammation in psoriasis","volume":"147","author":"Srivastava","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib107","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2015.07.001","article-title":"Interferon-\u03bb: Immune Functions at Barrier Surfaces and Beyond","volume":"43","author":"Lazear","year":"2015","journal-title":"Immunity"},{"issue":"18","key":"10.1016\/j.biopha.2023.115603_bib108","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1074\/jbc.R117.777102","article-title":"Contribution of type III interferons to antiviral immunity: location, location, location","volume":"292","author":"Kotenko","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2023.115603_bib109","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and Distinct Functions of Type I and Type III Interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.biopha.2023.115603_bib110","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1073\/pnas.1916897117","article-title":"Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus","volume":"117","author":"Goel","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.biopha.2023.115603_bib111","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1080\/08820139.2022.2036187","article-title":"Association between Psoriasis Disease and IFN-\u03bb Gene Polymorphisms","volume":"51","author":"Yilmaz","year":"2022","journal-title":"Immunol. Investig."},{"issue":"5","key":"10.1016\/j.biopha.2023.115603_bib112","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.biopha.2023.115603_bib113","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1172\/JCI200422147","article-title":"Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities","volume":"113","author":"Nickoloff","year":"2004","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.biopha.2023.115603_bib114","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib115","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/JLB.5MR0120-439R","article-title":"Keratinocyte: A trigger or an executor of psoriasis?","volume":"108","author":"Ni","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115603_bib116","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1084\/jem.20090480","article-title":"Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8","volume":"206","author":"Ganguly","year":"2009","journal-title":"J. Exp. Med."},{"issue":"7162","key":"10.1016\/j.biopha.2023.115603_bib117","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2023.115603_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2022.100116","article-title":"The relapse of psoriasis: mechanisms and mysteries","volume":"2","author":"Tian","year":"2022","journal-title":"JID Innov.: Ski. Sci. Mol. Popul. Health"},{"issue":"4","key":"10.1016\/j.biopha.2023.115603_bib119","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.immuni.2019.03.011","article-title":"The immunobiology of the interleukin-12 family: room for discovery","volume":"50","author":"Tait Wojno","year":"2019","journal-title":"Immunity"},{"issue":"7852","key":"10.1016\/j.biopha.2023.115603_bib120","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41586-021-03188-w","article-title":"Skin-resident innate lymphoid cells converge on a pathogenic effector state","volume":"592","author":"Bielecki","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biopha.2023.115603_bib121","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","article-title":"Imiquimod-induced psoriasis in mice depends on the IL-17 signaling of keratinocytes","volume":"139","author":"Moos","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"12","key":"10.1016\/j.biopha.2023.115603_bib122","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1038\/jid.2011.234","article-title":"Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis","volume":"131","author":"Carrier","year":"2011","journal-title":"J. Invest. Dermatol."},{"issue":"33","key":"10.1016\/j.biopha.2023.115603_bib123","doi-asserted-by":"crossref","first-page":"E3422","DOI":"10.1073\/pnas.1400513111","article-title":"IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms","volume":"111","author":"Ha","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib124","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.immuni.2012.04.010","article-title":"The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury","volume":"37","author":"Lai","year":"2012","journal-title":"Immunity"},{"issue":"13","key":"10.1016\/j.biopha.2023.115603_bib125","doi-asserted-by":"crossref","first-page":"9358","DOI":"10.1074\/jbc.C600321200","article-title":"STAT3 regulates cytokine-mediated generation of inflammatory helper T cells","volume":"282","author":"Yang","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2023.115603_bib126","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib127","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib128","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/cei.12952","article-title":"Production of complement components by cells of the immune system","volume":"188","author":"Lubbers","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115603_bib129","doi-asserted-by":"crossref","first-page":"R218","DOI":"10.1186\/ar4057","article-title":"Mannose binding lectin: a biomarker of systemic lupus erythematosus disease activity","volume":"14","author":"Panda","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2023.115603_bib130","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/1346-8138.16323","article-title":"Mannan-binding lectin exacerbates the severity of psoriasis by promoting plasmacytoid dendritic cell differentiation via the signal transducer and activator of transcription 3-interferon regulatory factor 8 axis","volume":"49","author":"Zeng","year":"2022","journal-title":"J. Dermatol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115603_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084190","article-title":"Type I Interferon Production of Plasmacytoid Dendritic Cells under Control","volume":"22","author":"Bencze","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2023.115603_bib132","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jid.2019.08.444","article-title":"IL-36 Promotes Systemic IFN-I Responses in Severe Forms of Psoriasis","volume":"140","author":"Catapano","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2023.115603_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103808","article-title":"SIDT1 plays a key role in type I IFN responses to nucleic acids in plasmacytoid dendritic cells and mediates the pathogenesis of an imiquimod-induced psoriasis model","volume":"76","author":"Morell","year":"2022","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.biopha.2023.115603_bib134","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.jid.2022.02.018","article-title":"OAS1, OAS2, and OAS3 contribute to epidermal keratinocyte proliferation by regulating cell cycle and augmenting IFN-1\u2013Induced Jak1\u2013signal transducer and activator of transcription 1 phosphorylation in psoriasis","volume":"142","author":"Huang","year":"2022","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2023.115603_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02314","article-title":"Regulatory NLRs control the RLR-mediated type i interferon and inflammatory responses in human dendritic cells","volume":"9","author":"Fekete","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115603_bib136","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/glia.22499","article-title":"Human astrocytes express a novel NLRP2 inflammasome","volume":"61","author":"Minkiewicz","year":"2013","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.biopha.2023.115603_bib137","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.immuni.2012.02.001","article-title":"An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages","volume":"36","author":"Khare","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib138","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.immuni.2012.07.006","article-title":"The NLRP12 inflammasome recognizes Yersinia pestis","volume":"37","author":"Vladimer","year":"2012","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.biopha.2023.115603_bib139","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.cell.2015.10.048","article-title":"Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling","volume":"163","author":"Levy","year":"2015","journal-title":"Cell"},{"issue":"7660","key":"10.1016\/j.biopha.2023.115603_bib140","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nature22967","article-title":"Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells","volume":"546","author":"Zhu","year":"2017","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.biopha.2023.115603_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012154","article-title":"Interactions between the NLRP3-dependent IL-1\u03b2 and the type I interferon pathways in human plasmacytoid dendritic cells","volume":"23","author":"Bencze","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2023.115603_bib142","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jid.2020.07.012","article-title":"Enhanced inflammasome activity in patients with psoriasis promotes systemic inflammation","volume":"141","author":"Verma","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2023.115603_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.739514","article-title":"Circulating metabolomic signature in generalized pustular psoriasis blunts monocyte hyperinflammation by triggering amino acid response","volume":"12","author":"Yu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.115603_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00478","article-title":"Mononuclear phagocyte activation is associated with the immunopathology of psoriasis","volume":"11","author":"Costa","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115603_bib145","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5455\/medarh.2018.72.410-413","article-title":"Serum concentrations of interferon gamma (IFN-\u03b3) in patients with psoriasis: correlation with clinical type and severity of the disease","volume":"72","author":"Kurtovic","year":"2018","journal-title":"Med. Arch."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib146","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0923-1811(03)00107-5","article-title":"Downregulation of TGFbeta isoforms and their receptors contributes to keratinocyte hyperproliferation in psoriasis vulgaris","volume":"33","author":"Doi","year":"2003","journal-title":"J. Dermatol. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2023.115603_bib147","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.jid.2017.06.005","article-title":"TGF\u03b2\/SMAD\/microRNA-486-3p Signaling Axis Mediates Keratin 17 Expression and Keratinocyte Hyperproliferation in Psoriasis","volume":"137","author":"Jiang","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib148","doi-asserted-by":"crossref","DOI":"10.3390\/genes14010103","article-title":"Loss of function TGFBR2 variant as a contributing factor in generalized pustular psoriasis and adult-onset immunodeficiency","volume":"14","author":"Kantaputra","year":"2022","journal-title":"Genes"},{"issue":"16","key":"10.1016\/j.biopha.2023.115603_bib149","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa1100721","article-title":"Inflammatory skin and bowel disease linked to ADAM17 deletion","volume":"365","author":"Blaydon","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biopha.2023.115603_bib150","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.20112258","article-title":"Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation","volume":"209","author":"Franzke","year":"2012","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.biopha.2023.115603_bib151","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ajhg.2011.09.001","article-title":"Mutations in CSTA, encoding Cystatin A, underlie exfoliative ichthyosis and reveal a role for this protease inhibitor in cell-cell adhesion","volume":"89","author":"Blaydon","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.biopha.2023.115603_bib152","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1111\/pde.12092","article-title":"Acral peeling skin syndrome resulting from a homozygous nonsense mutation in the CSTA gene encoding cystatin A","volume":"30","author":"Krunic","year":"2013","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.biopha.2023.115603_bib153","article-title":"A role for whey acidic protein four-disulfide-core 12 (WFDC12) in the pathogenesis and development of psoriasis disease","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115603_bib154","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.dci.2007.12.002","article-title":"Crustins: enigmatic WAP domain-containing antibacterial proteins from crustaceans","volume":"32","author":"Smith","year":"2008","journal-title":"Dev. Comp. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115603_bib155","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1042\/BST0391437","article-title":"SLPI and elafin: multifunctional antiproteases of the WFDC family","volume":"39","author":"Scott","year":"2011","journal-title":"Biochem. Soc. Trans."},{"issue":"5","key":"10.1016\/j.biopha.2023.115603_bib156","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1042\/BST0391409","article-title":"WAP domain proteins as modulators of mucosal immunity","volume":"39","author":"Wilkinson","year":"2011","journal-title":"Biochem. Soc. Trans."},{"issue":"9","key":"10.1016\/j.biopha.2023.115603_bib157","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1600-0625.2011.01295.x","article-title":"A protective role of complement component 3 in T cell-mediated skin inflammation","volume":"20","author":"Purwar","year":"2011","journal-title":"Exp. Dermatol."},{"issue":"7","key":"10.1016\/j.biopha.2023.115603_bib158","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.4049\/jimmunol.177.7.4444","article-title":"Induction of C3 and CCL2 by C3a in keratinocytes: a novel autocrine amplification loop of inflammatory skin reactions","volume":"177","author":"Purwar","year":"2006","journal-title":"J. Immunol. (Baltim., Md: 1950)"},{"key":"10.1016\/j.biopha.2023.115603_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106692","article-title":"Complement component 3 prevents imiquimod-induced psoriatic skin inflammation by inhibiting apoptosis in mice","volume":"85","author":"Zheng","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib160","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4049\/jimmunol.2001310","article-title":"IFN-\u03b3 Drives Human Monocyte Differentiation into Highly Proinflammatory Macrophages That Resemble a Phenotype Relevant to Psoriasis","volume":"207","author":"Luque-Martin","year":"2021","journal-title":"J. Immunol. (Baltim., Md: 1950)"},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib161","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jdermsci.2023.03.007","article-title":"Translation-dependent skin hyperplasia is promoted by type 1\/17 inflammation in psoriasis","volume":"110","author":"Xu","year":"2023","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib162","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/exd.14431","article-title":"Decrease of ceramides with long-chain fatty acids in psoriasis: Possible inhibitory effect of interferon gamma on chain elongation","volume":"31","author":"Kim","year":"2022","journal-title":"Exp. Dermatol."},{"issue":"44","key":"10.1016\/j.biopha.2023.115603_bib163","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2117523119","article-title":"Up-regulation of BTN3A1 on CD14(+) cells promotes V\u03b39V\u03b42 T cell activation in psoriasis","volume":"119","author":"Zhou","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.biopha.2023.115603_bib164","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.4049\/jimmunol.1600913","article-title":"Butyrophilin 3A\/CD277-dependent activation of human \u03b3\u03b4 T cells: accessory cell capacity of distinct leukocyte populations","volume":"197","author":"Nerdal","year":"2016","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115603_bib165","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.1100804","article-title":"Identification of a novel proinflammatory human skin-homing V\u03b39V\u03b42 T cell subset with a potential role in psoriasis","volume":"187","author":"Laggner","year":"2011","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib166","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.gene.6364348","article-title":"Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1\/IL-29)","volume":"8","author":"Jordan","year":"2007","journal-title":"Genes Immun."},{"issue":"4","key":"10.1016\/j.biopha.2023.115603_bib167","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2567.2008.02862.x","article-title":"Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro","volume":"125","author":"Srinivas","year":"2008","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.biopha.2023.115603_bib168","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/sj.gene.6364382","article-title":"Human interferon lambda-1 (IFN-lambda1\/IL-29) modulates the Th1\/Th2 response","volume":"8","author":"Jordan","year":"2007","journal-title":"Genes Immun."},{"issue":"4","key":"10.1016\/j.biopha.2023.115603_bib169","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.abd.2020.11.007","article-title":"Enhanced serum interferon-lambda 1 interleukin-29 levels in patients with psoriasis vulgaris","volume":"96","author":"Fu","year":"2021","journal-title":"An. Bras. De. Dermatol."},{"key":"10.1016\/j.biopha.2023.115603_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109585","article-title":"Kaempferol modulates IFN-\u03b3 induced JAK-STAT signaling pathway and ameliorates imiquimod-induced psoriasis-like skin lesions","volume":"114","author":"Li","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2023.115603_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116746","article-title":"Centella asiatica alleviates psoriasis through JAK\/STAT3-mediated inflammation: an in vitro and in vivo study","volume":"317","author":"Lin","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.115603_bib172","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cca.2008.04.005","article-title":"Cytokines and anticytokines in psoriasis","volume":"394","author":"Pietrzak","year":"2008","journal-title":"Clin. Chim. Acta; Int. J. Clin. Chem."},{"issue":"10","key":"10.1016\/j.biopha.2023.115603_bib173","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI200318986","article-title":"Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model","volume":"112","author":"Villadsen","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"7230","key":"10.1016\/j.biopha.2023.115603_bib174","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nature07537","article-title":"A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity","volume":"457","author":"Cella","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.115603_bib175","article-title":"NK cells and psoriasis","volume":"2011","author":"Dunphy","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.biopha.2023.115603_bib176","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.nutres.2020.01.005","article-title":"Curcumin mediates attenuation of pro-inflammatory interferon \u03b3 and interleukin 17 cytokine responses in psoriatic disease, strengthening its role as a dietary immunosuppressant","volume":"75","author":"Skyvalidas","year":"2020","journal-title":"Nutr. Res."},{"key":"10.1016\/j.biopha.2023.115603_bib177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-0-387-46401-5_1","article-title":"Curcumin: the Indian solid gold","volume":"595","author":"Aggarwal","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib178","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/13813450802033958","article-title":"Role of curcumin in health and disease","volume":"114","author":"Pari","year":"2008","journal-title":"Arch. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.biopha.2023.115603_bib179","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12026-023-09361-9","article-title":"Gallic acid diminishes pro-inflammatory interferon-\u03b3- and interleukin-17-producing sub-populations in vitro in patients with psoriasis","volume":"71","author":"Tsiogkas","year":"2023","journal-title":"Immunol. Res."},{"key":"10.1016\/j.biopha.2023.115603_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106070","article-title":"Effects of luteolin on treatment of psoriasis by repressing HSP90","volume":"79","author":"Lv","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2023.115603_bib181","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.42791","article-title":"Paradoxical tumor necrosis factor-Alpha (TNF-\u03b1) inhibitor-induced psoriasis: a systematic review of pathogenesis, clinical presentation, and treatment","author":"Chokshi","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib182","first-page":"380","article-title":"Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series","volume":"34","author":"Cohen","year":"2007","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib183","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02466-4","article-title":"TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis","volume":"9","author":"Conrad","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib184","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13075-021-02558-z","article-title":"Differential impacts of TNF\u03b1 inhibitors on the transcriptome of Th cells","volume":"23","author":"Ho","year":"2021","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.biopha.2023.115603_bib185","article-title":"The effect of secukinumab treatment for psoriasis on serum cytokines and correlation with disease severity","volume":"29","author":"Wu","year":"2023","journal-title":"Ski. Res. Technol.: Off. J. Int. Soc. Bioeng. Ski. (ISBS) Int. Soc. Digit. Imaging Ski. (ISDIS) Int. Soc. Ski. Imaging (ISSI)"},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib186","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jdermsci.2020.09.002","article-title":"A novel role of IL-17A in contributing to the impaired suppressive function of Tregs in psoriasis","volume":"101","author":"Liu","year":"2021","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.biopha.2023.115603_bib187","doi-asserted-by":"crossref","unstructured":"Kruszniewska-Rajs C., Krawczyk A., Gola J., Wcis\u0142o-Dziadecka D., Strzalka-Mrozik B. Expression of genes related to inflammation - IL-6, IL-8, and IFN-\u03b3 in monitoring ustekinumab therapy: preliminary results. Postepy dermatologii i alergologii. 2022 Dec;39(6):1040\u20131047. eng. Epub 2023\/01\/24. doi:\u300810.5114\/ada.2022.122602\u3009. Cited in: Pubmed; PMID 36686017.","DOI":"10.5114\/ada.2022.122602"},{"key":"10.1016\/j.biopha.2023.115603_bib188","doi-asserted-by":"crossref","DOI":"10.17235\/reed.2023.9745\/2023","article-title":"Infliximab-induced psoriasis in an ulcerative colitis patient successfully treated with guselkumab","author":"Dai","year":"2023","journal-title":"Rev. Esp. De. Enferm. Dig."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib189","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/cts.13435","article-title":"First-in-human study of deucravacitinib: a selective, potent, allosteric small-molecule inhibitor of tyrosine kinase 2","volume":"16","author":"Catlett","year":"2023","journal-title":"Clin. Transl. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2023.115603_bib190","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.4049\/jimmunol.2000951","article-title":"Noncytotoxic inhibition of the immunoproteasome regulates human immune cells in vitro and suppresses cutaneous inflammation in the mouse","volume":"206","author":"Ah Kioon","year":"2021","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115603_bib191","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/jamadermatol.2022.0029","article-title":"Efficacy and safety of upadacitinib in patients with moderate to severe atopic dermatitis: analysis of follow-up data from the measure up 1 and measure up 2 randomized clinical trials","volume":"158","author":"Simpson","year":"2022","journal-title":"JAMA Dermatol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115603_bib192","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaad.2021.04.085","article-title":"Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies","volume":"85","author":"Papp","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115603_bib193","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamadermatol.2020.1406","article-title":"Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis: a randomized clinical trial","volume":"156","author":"Silverberg","year":"2020","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.biopha.2023.115603_bib194","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/DDDT.S82599","article-title":"Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis","volume":"10","author":"Di Lernia","year":"2016","journal-title":"Drug Des., Dev. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2023.115603_bib195","first-page":"568","article-title":"Efficacy of tofacitinib for the treatment of moderate-to-severe chronic plaque psoriasis in patient subgroups from two randomised phase 3 trials","volume":"15","author":"Menter","year":"2016","journal-title":"J. Drugs Dermatol.: JDD"},{"issue":"4","key":"10.1016\/j.biopha.2023.115603_bib196","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jaci.2015.12.1318","article-title":"Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: a randomized phase 2 study","volume":"137","author":"Krueger","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2023.115603_bib197","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7897263","article-title":"Selective immunomodulation of inflammatory pathways in keratinocytes by the janus kinase (JAK) inhibitor tofacitinib: implications for the employment of JAK-targeting drugs in psoriasis","volume":"2018","author":"Morelli","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"9","key":"10.1016\/j.biopha.2023.115603_bib198","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2023.115603_bib199","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-pathol-011110-130230","article-title":"Mesenchymal stem cells: mechanisms of inflammation","volume":"6","author":"Singer","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.biopha.2023.115603_bib200","first-page":"1","article-title":"Effects of Wharton's jelly-derived mesenchymal stem cells on neonatal neutrophils.","volume":"8","author":"Khan","year":"2015","journal-title":"J. Inflamm. Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.115603_bib201","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.imbio.2012.02.007","article-title":"Mesenchymal stem cells promote neutrophil activation by inducing IL-17 production in CD4+ CD45RO+ T cells","volume":"218","author":"Hsu","year":"2013","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib202","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","article-title":"Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study","volume":"11","author":"Connick","year":"2012","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115603_bib203","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbmt.2009.11.006","article-title":"Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report","volume":"16","author":"Zhou","year":"2010","journal-title":"Biol. Blood Marrow Transplant.: J. Am. Soc. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.biopha.2023.115603_bib204","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00384-012-1581-9","article-title":"Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I\/IIa clinical trial","volume":"28","author":"de la Portilla","year":"2013","journal-title":"Int. J. Colorectal Dis."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib205","doi-asserted-by":"crossref","DOI":"10.1186\/scrt55","article-title":"Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology","volume":"2","author":"Maumus","year":"2011","journal-title":"Stem Cell Res. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib206","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/ar4520","article-title":"Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study","volume":"16","author":"Wang","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2023.115603_bib207","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6961052","article-title":"Mesenchymal stem cells alleviate moderate-to-severe psoriasis by reducing the production of type i interferon (IFN-I) by plasmacytoid dendritic cells (pDCs)","volume":"2019","author":"Chen","year":"2019","journal-title":"Stem Cells Int."},{"issue":"6","key":"10.1016\/j.biopha.2023.115603_bib208","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1172\/JCI97426","article-title":"MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation","volume":"128","author":"Wu","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2023.115603_bib209","article-title":"Small extracellular vesicles derived from MSCs have immunomodulatory effects to enhance delivery of ASO-210 for psoriasis treatment","volume":"10","author":"Zhang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115603_bib210","first-page":"157","volume":"42","author":"Wang","year":"2022","journal-title":"Chronic Spontan urticaria Treat. bloodletting Ther. Auricular Point sticking base xuanfu Theory.: a Random Control. Trial]. Zhongguo zhen jiu = Chin. Acupunct. moxibustion."},{"issue":"Pt A","key":"10.1016\/j.biopha.2023.115603_bib211","article-title":"Total glucosides of paeony alleviates scleroderma by inhibiting type I interferon responses","volume":"302","author":"Li","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2023.115603_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153779","article-title":"Gansui-Banxia Decoction extraction inhibits MDSCs accumulation via AKT \/STAT3\/ERK signaling pathways to regulate antitumor immunity in C57bl\/6 mice","volume":"93","author":"Feng","year":"2021","journal-title":"Phytomedicine: Int. J. Phytother. Phytopharm."},{"issue":"21","key":"10.1016\/j.biopha.2023.115603_bib213","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113228","article-title":"Ex vivo treatment with allogenic mesenchymal stem cells of a healthy donor on peripheral blood mononuclear cells of patients with severe alopecia areata: targeting dysregulated T cells and the acquisition of immunotolerance","volume":"23","author":"Kim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115603_bib214","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1029671","article-title":"Bioengineered MSC-derived exosomes in skin wound repair and regeneration","volume":"11","author":"Zhao","year":"2023","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223014014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223014014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:08:48Z","timestamp":1776460128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223014014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":214,"alternative-id":["S0753332223014014"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115603","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role and application of three IFN-related reactions in psoriasis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115603"}}